Opsona Therapeutics Ltd.
3 clinical trials · Sponsor
◉ Watch Opsona Therapeutics Ltd.
| Record | Firm | Date |
|---|---|---|
| Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome (NCT03337451) | Opsona Therapeutics Ltd. | 2018-02-27 |
Track Opsona Therapeutics Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.